Elbits profit surges 30 percent as its order backlog hits record amid multifront war - MSN

EMTC-M Stock   18.10  1.70  8.59%   
About 61% of Elbit Medical's investor base is looking to short. The analysis of current outlook of investing in Elbit Medical Technologies suggests that many traders are alarmed regarding Elbit Medical's prospects. The current market sentiment, together with Elbit Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Elbit Medical Techno stock news signals to limit their universe of possible portfolio assets.
  
Elbits profit surges 30 percent as its order backlog hits record amid multifront war MSN

Read at news.google.com
Google News at Macroaxis
  

Elbit Medical Fundamental Analysis

We analyze Elbit Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elbit Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elbit Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Operating Margin

Operating Margin Comparative Analysis

Elbit Medical is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Elbit Medical Techno Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Elbit Medical stock to make a market-neutral strategy. Peer analysis of Elbit Medical could also be used in its relative valuation, which is a method of valuing Elbit Medical by comparing valuation metrics with similar companies.

Complementary Tools for Elbit Stock analysis

When running Elbit Medical's price analysis, check to measure Elbit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elbit Medical is operating at the current time. Most of Elbit Medical's value examination focuses on studying past and present price action to predict the probability of Elbit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elbit Medical's price. Additionally, you may evaluate how the addition of Elbit Medical to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bonds Directory
Find actively traded corporate debentures issued by US companies